THRA Antikörper (N-Term)
Kurzübersicht für THRA Antikörper (N-Term) (ABIN6104440)
Target
Alle THRA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Aufreinigung
- Affinity Chromatography
-
Immunogen
- Synthesized peptide derived from the N-terminal region of human TRalpha.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Aliquot and store at -20 °C or -80 °C. Avoid repeated freeze/thaw cycles.
-
-
- THRA (Thyroid Hormone Receptor, alpha (THRA))
-
Andere Bezeichnung
- THRA
-
Gen-ID
- 7067
-
UniProt
- P10827
-
Pathways
- Nuclear Receptor Transcription Pathway, Steroid Hormone Mediated Signaling Pathway, Sensory Perception of Sound, Cellular Response to Molecule of Bacterial Origin, Regulation of Lipid Metabolism by PPARalpha, Regulation of Muscle Cell Differentiation, Maintenance of Protein Location, Skeletal Muscle Fiber Development
Target
-